DailyWealth Investment Newsletter  

About DailyWealth Premium Content DailyWealth Archive
DailyWealth Investment Newsletter DailyWealth Contributors DailyWealth Resources DailyWealth Market Window
 
DailyWealth Print Edition Print Edition | Sponsored Link:
True Wealth Login

The Decade's Most Irresistible Opportunity... Don't Hesitate
By Dr. Steve Sjuggerud
July 18, 2008

On Wednesday I bought a variety of stocks...

I'd been trying to restrain myself. Just about everything has been in a downtrend this year. But things are just too irresistible now.

If you're a longtime reader, you know my criteria for buying... The ideal situation is when you can get all three of these together: 1) cheap, 2) hated, and 3) in the beginning of an uptrend.

Right now, the first two of our criteria are at "best in a decade" levels. So, though it feels extremely risky out there now, it's probably the least risky time to buy stocks in the last decade. Let me show you...
Advertisement

Just recently, the "Investors Intelligence" poll found that professional investors are more bearish than they've been at any time in the last decade. As the chart below shows, whenever investors get really bearish, stocks are generally near a short-term bottom.

I put a vertical line in whenever investor sentiment reached a bearish extreme. In hindsight, it always turned out to be good for a short-term rally in stocks. In bear markets, those rallies are short. In bull markets, the rallies are strong.

Stocks Are Hated... Time to Buy!
You think gas is expensive now? Consider this:

So judging by the Investors Intelligence poll, we have one of our three criteria: Stocks are "hated" right now.

Stocks also meet our "cheap" criteria... Stocks are cheaper now than they've been in more than a decade. According to Bloomberg, the forward price-to-earnings ratio for the Dow is only 12, and it's only 13 and change for the S&P 500 index.

The one criterion we're missing, of course, is the uptrend. No sector in the U.S. is up over the last 12 months, except a few oil stocks. It's been a horrible grind... until Wednesday of this week.

Tuesday felt like "capitulation" to me – investors finally threw in the towel. Wednesday's rally confirmed it. That we held on to those gains on Thursday morning was further confirmation.

When it feels safest to buy – when everyone else is talking about it – it's often the most risky. In 2005, all the talk was how "you couldn't go wrong" in real estate. In 1999, it was stocks. Now it feels like "you can't go right" investing in stocks – which is usually when it's least risky. Sounds convoluted, but it's usually true.

Related Articles

The One Positive Thing About This Bear Market

How to Prosper in the Midst of a Growing Financial Crisis

While we don't have confirmation of the uptrend yet, we do have two of the three things I want to see – and they're more attractive now than they've been in over a decade. It wouldn't surprise me at all to see stocks start a nice rally from here.

And if that happens – if we see the uptrend – I'll be buying more... We'll have all three buying criteria in place. That rarely happens, and we should take advantage of it.

If it happens, don't hesitate. Buy.

Good investing,

Steve

Email a Friend

Delicious
Reddit

Digg

RSS

A POTENTIAL 500% BIOTECH RALLY IS AROUND THE CORNER

More on the "acting well" biotechnology sector...

As we've covered before, the biotech sector is a speculator's best friend. The investing public just loves a potential cure for cancer. So biotech bull markets are spectacular... often returning 300%-500%. A small stake in a biotech rally will make your entire year. A large stake will make your retirement.

We could be at the start of one of those great biotech bull markets. Several weeks ago, we ran a chart of the PowerShares Biotech ETF (PBE). While the broad market crashed in May and June, the PBE held like a rock.

Today's chart is another sign that a biotech bull market may be around the corner. It's the past year in the S&P Biotech Index ETF (XBI). This fund is full of midsized biotech companies with actual sales... sales a weak economy won't wreck.

The XBI hasn't just "held like a rock" during the past three months, it has gained 12%. For a sector with a risky reputation, this performance is amazing. The fuse is sparking on the biotech rocket.

SPDR S&P Biotech Index

For years, mortgage giants Fannie Mae and Freddie Mac tenaciously worked to nurture, and then protect, their financial empires by invoking the political sacred cow of homeownership and fielding an army of lobbyists, power brokers and political contributors.

New attention is being focused on the bruised mortgage companies as the Bush administration presses its rescue plan to Congress. Some lawmakers have challenged the plan's open-ended nature and expressed fears of a potential big taxpayer bailout in an election year.

Over the past decade, both Fannie and Freddie made the list of Washington's top 20 lobbying spenders. They spent a combined $170 million to cultivate allies during that period, a bit less than the American Medical Association and a bit more than General Electric.

"They have always understood that the political risk was huge for them, and they put millions of dollars into using contributions, jobs and consulting contracts to stay in the good graces of people in power," says Wright Andrews, a veteran banking lobbyist. "They had both parties – and particularly the Democrats – under incredible control."

Associated Press

Australia's S&P/ASX 200 Index, currently trading at recession levels, is nearing its bottom, according to strategists at Morgan Stanley.

The Australian benchmark index is valued at about 11.5 times estimated fiscal 2009 profits, about 8 percent below the level appropriate if the economy was in recession, analysts led by Toby Walker said in a strategy note today.

"We do not have much further to fall," the strategists said. "With the market now close to what we think is a recession multiple, the environment is becoming more conducive to looking for contrarian names."
– Bloomberg

Advertisement

DailyWealth is Dr. Steve Sjuggerud's FREE daily e-Letter

To receive Steve's best investment ideas each month, try a no-risk trial subscription to his monthly advisory, True Wealth.

Get started now.

How Americans Should React to the Fannie Mae Bailout
July 17, 2008

This Gadget Will Revolutionize Our Power Supply
July 16, 2008

The Best-Performing Stock Manager in America This Year
July 15, 2008

A Visit to the World's Next Agricultural Superpower
July 14, 2008

An Extraordinary Income Opportunity in the Energy Market
July 12, 2008


Home | About DailyWealth | Premium Content | DailyWealth Archive | Contributors
DailyWealth Resources | Research Reports | Privacy Policy

Customer Service: 1-888-261-2693 – Copyright 2008 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202